BioCentury
ARTICLE | Clinical News

GenESA System using computer-controlled delivery of arbutamine data

November 20, 1995 8:00 AM UTC

Three reports detailing the Phase III data for the company's stress-testing system were published in the Journal of the American College of Cardiology.

As published, sensitivity for detecting ischemia by either angina or ST segment change was 84 percent for arbutamine versus 75 percent for exercise testing (p=0.014) in 210 patients. ...